195 related articles for article (PubMed ID: 26610639)
1. Hunting down factor VIII in the immunopeptidome.
Hartholt RB; Peyron I; Voorberg J
Cell Immunol; 2016 Mar; 301():59-64. PubMed ID: 26610639
[TBL] [Abstract][Full Text] [Related]
2. Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition.
Schneidman-Duhovny D; Khuri N; Dong GQ; Winter MB; Shifrut E; Friedman N; Craik CS; Pratt KP; Paz P; Aswad F; Sali A
PLoS One; 2018; 13(11):e0206654. PubMed ID: 30399156
[TBL] [Abstract][Full Text] [Related]
3. CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia A.
Jacquemin M; Vantomme V; Buhot C; Lavend'homme R; Burny W; Demotte N; Chaux P; Peerlinck K; Vermylen J; Maillere B; van der Bruggen P; Saint-Remy JM
Blood; 2003 Feb; 101(4):1351-8. PubMed ID: 12393451
[TBL] [Abstract][Full Text] [Related]
4. Limited promiscuity of HLA-DRB1 presented peptides derived of blood coagulation factor VIII.
van Haren SD; Wroblewska A; Herczenik E; Kaijen PH; Ruminska A; ten Brinke A; Meijer AB; Voorberg J
PLoS One; 2013; 8(11):e80239. PubMed ID: 24244658
[TBL] [Abstract][Full Text] [Related]
5. CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice.
Steinitz KN; van Helden PM; Binder B; Wraith DC; Unterthurner S; Hermann C; Schuster M; Ahmad RU; Weiller M; Lubich C; de la Rosa M; Schwarz HP; Reipert BM
Blood; 2012 Apr; 119(17):4073-82. PubMed ID: 22394599
[TBL] [Abstract][Full Text] [Related]
6. Requirements for immune recognition and processing of factor VIII by antigen-presenting cells.
van Haren SD; Wroblewska A; Fischer K; Voorberg J; Herczenik E
Blood Rev; 2012 Jan; 26(1):43-9. PubMed ID: 22036515
[TBL] [Abstract][Full Text] [Related]
7. Factor VIII inhibitors: role of von Willebrand factor on the uptake of factor VIII by dendritic cells.
Kaveri SV; Dasgupta S; Andre S; Navarrete AM; Repessé Y; Wootla B; Lacroix-Desmazes S
Haemophilia; 2007 Dec; 13 Suppl 5():61-4. PubMed ID: 18078399
[TBL] [Abstract][Full Text] [Related]
8. Dangerous liaisons: how the immune system deals with factor VIII.
Wroblewska A; Reipert BM; Pratt KP; Voorberg J
J Thromb Haemost; 2013 Jan; 11(1):47-55. PubMed ID: 23140211
[TBL] [Abstract][Full Text] [Related]
9. Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways.
Thiele F; Tao S; Zhang Y; Muschaweckh A; Zollmann T; Protzer U; Abele R; Drexler I
J Virol; 2015 Mar; 89(5):2698-709. PubMed ID: 25520512
[TBL] [Abstract][Full Text] [Related]
10. Sensitization of CD4+ T cells to coagulation factor VIII: response in congenital and acquired hemophilia patients and in healthy subjects.
Reding MT; Wu H; Krampf M; Okita DK; Diethelm-Okita BM; Christie BA; Key NS; Conti-Fine BM
Thromb Haemost; 2000 Oct; 84(4):643-52. PubMed ID: 11057864
[TBL] [Abstract][Full Text] [Related]
11. Comparative profiling of HLA-DR and HLA-DQ associated factor VIII peptides presented by monocyte-derived dendritic cells.
Peyron I; Hartholt RB; Pedró-Cos L; van Alphen F; Brinke AT; Lardy N; Meijer AB; Voorberg J
Haematologica; 2018 Jan; 103(1):172-178. PubMed ID: 29025906
[TBL] [Abstract][Full Text] [Related]
12. Modulating the microenvironment during FVIII uptake influences the nature of FVIII-peptides presented by antigen-presenting cells.
Lubich C; Steinitz KN; Hoelbl B; Prenninger T; van Helden PM; Weiller M; Reipert BM
Front Immunol; 2022; 13():975680. PubMed ID: 36389737
[TBL] [Abstract][Full Text] [Related]
13. In silico calculated affinity of FVIII-derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene.
Pashov AD; Calvez T; Gilardin L; Maillère B; Repessé Y; Oldenburg J; Pavlova A; Kaveri SV; Lacroix-Desmazes S
Haemophilia; 2014 Mar; 20(2):176-84. PubMed ID: 24118514
[TBL] [Abstract][Full Text] [Related]
14. B-cell and T-cell epitopes in anti-factor VIII immune responses.
Pratt KP; Thompson AR
Clin Rev Allergy Immunol; 2009 Oct; 37(2):80-95. PubMed ID: 19184559
[TBL] [Abstract][Full Text] [Related]
15. T cell recognition of the A2 domain of coagulation factor VIII in hemophilia patients and healthy subjects.
Hu GL; Okita DK; Conti-Fine BM
J Thromb Haemost; 2004 Nov; 2(11):1908-17. PubMed ID: 15550021
[TBL] [Abstract][Full Text] [Related]
16. T cells from hemophilia A subjects recognize the same HLA-restricted FVIII epitope with a narrow TCR repertoire.
Ettinger RA; Paz P; James EA; Gunasekera D; Aswad F; Thompson AR; Matthews DC; Pratt KP
Blood; 2016 Oct; 128(16):2043-2054. PubMed ID: 27471234
[TBL] [Abstract][Full Text] [Related]
17. Restricted BV gene usage by factor VIII-reactive CD4+ T cells in inhibitor-positive patients with severe hemophilia A.
Misra N; Bayry J; Pashov A; Kaveri SV; D'Oiron R; Stieltjes N; Roussel-Robert V; Kazatchkine MD; Boyer O; Lacroix-Desmazes S
Thromb Haemost; 2003 Nov; 90(5):813-22. PubMed ID: 14597975
[TBL] [Abstract][Full Text] [Related]
18. Human CD4+ T-cell epitope repertoire on the C2 domain of coagulation factor VIII.
Reding MT; Okita DK; Diethelm-Okita BM; Anderson TA; Conti-Fine BM
J Thromb Haemost; 2003 Aug; 1(8):1777-84. PubMed ID: 12911593
[TBL] [Abstract][Full Text] [Related]
19. T-cell responses over time in a mild hemophilia A inhibitor subject: epitope identification and transient immunogenicity of the corresponding self-peptide.
James EA; Kwok WW; Ettinger RA; Thompson AR; Pratt KP
J Thromb Haemost; 2007 Dec; 5(12):2399-407. PubMed ID: 18034765
[TBL] [Abstract][Full Text] [Related]
20. Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response.
Zhou G; Ding ZC; Fu J; Levitsky HI
J Immunol; 2011 Feb; 186(4):2148-55. PubMed ID: 21242518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
